Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New mapping tool aims to speed up heart procedure

NCT ID NCT06939478

Knowledge-focused Sponsor: Heart Rhythm Clinical and Research Solutions, LLC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a special mapping tool called vMap can help doctors perform heart ablations more efficiently for people with irregular heartbeats (arrhythmias). Researchers tracked 112 patients to see if using vMap reduced procedure time and improved success rates. The goal was to gather information, not to prove a treatment works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

112 people

The number who actually took part.

Started

Aug 2025

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Study population will be derived from subjects scheduled for cardiac ablation who meet inclusion and exclusion criteria for the registry.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Retrospective Arm: Inclusion Criteria: 1. Patients who had a standard of care cardiac ablation (de novo or repeat) where the vMap equipment was used. 2. The patient can provide written informed consent, if applicable. 3. The patient is greater than or equal to 18 years old Prospective Arm: Inclusion Criteria: 1. Patients who had a standard of care cardiac ablation (de novo or repeat) where the vMap equipment was used. 2. The patient can provide written informed consent, if applicable. 3. The patient is greater than or equal to 18 years old Exclusion Criteria: Participants who meet any one of the following criteria will be a screen failure and excluded from participation: 1. Non-inducible arrhythmia (unless pre-mapped via vMap prior to the procedure). 2. Patients in whom no ablation was performed using the vMap equipment. 3. Inability to obtain 12-lead ECG of sufficient quality for vMap analysis. 4. In the opinion of the Investigator, the participant is not suitable and has a contraindication to undergo the ablation procedure.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Arrhythmias, cardiac are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac cardiac rhythm disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Arrhythmias, cardiac

Contacts and locations

Locations

  • Ascension St. Vincent's

    Jacksonville, Florida, 43304, United States

  • Grandview Medical Center

    Birmingham, Alabama, 35243, United States

  • HCA Florida Healthcare

    Miami, Florida, 33133, United States

  • OhioHealth

    Columbus, Ohio, 43214, United States

  • Penn Presbyterian Medical Center

    Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.